EyePoint Pharmaceuticals, Inc. Consulting Agreements
1 Contracts & Agreements
- Consulting Agreement dated December 18, 2023 by and between Eyepoint Pharmaceuticals, Inc. and John Landis, PhD (Filed With SEC on March 8, 2024)
